Fund Holdings — Vivo Capital, LLC

Total Portfolio Value
$1.20B
Total Bought
$301.23M
Total Sold
$692.72M
Net Transaction
-$391.49M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Erasca Inc(ERAS)9,273,42812,151,480+2,878,05234,497196,61116.34%+162,114
Tango Therapeutics Inc(TNGX)2,154,7802,154,780019,09145,0783.75%+25,987
Corvus Pharmaceuticals Holdings(CRVS)2,234,5662,805,816+571,25017,20641,0493.41%+23,843
Sensei Biotherapeutics Inc(FTH)0722,020+722,020022,7581.89%+22,758
Arrivent BioPharma Inc(AVBP)0885,916+885,916020,4381.70%+20,438
Veradermics Inc(MANE)0300,000+300,000018,9451.57%+18,945
Dianthus Therapeutics Inc(DNTH)353,998353,998014,58829,7082.47%+15,119
Praxis Precision Medicines(PRAX)328,895338,895+10,00096,939109,1899.08%+12,250
AN2 Therapeutics Inc03,153,640+3,153,640010,7850.90%+10,785
Minerva Neurosciences Inc(NERV)4,322,7474,322,747017,37726,0452.17%+8,667
DBV Technologies SA(DBVT)2,461,6262,667,569+205,94347,18955,7264.63%+8,536
Onkure Therapeutics Inc(OKUR)01,927,710+1,927,71007,9810.66%+7,981
ALX Oncology Holdings Inc(ALXO)03,184,713+3,184,71306,3850.53%+6,385
Oric Pharmaceuticals Inc(ORIC)2,118,3841,848,786-269,59817,32823,4241.95%+6,096
Moonlake Immunotherapeutics(MLTX)1,000,0001,000,000013,18018,6401.55%+5,460
Alto Neuroscience Inc(ANRO)1,035,5511,035,551018,43323,2791.94%+4,846
Satellos Bioscience Inc(MSLE)0813,666+813,66604,5810.38%+4,581
Design Therapeutics Inc(DSGN)1,612,9031,612,903015,12917,1611.43%+2,032
LB Pharmaceuticals Inc(LBRX)800,000800,000017,80819,7281.64%+1,920
Surrozen Inc(SRZN)260,000260,00005,8767,5740.63%+1,698
Bright Minds Biosciences Inc(DRUG)501,617557,172+55,55539,14640,6573.38%+1,511
Unicycive Therapeutics(UNCY)1,789,9161,789,916010,32811,7780.98%+1,450
Compass Pathway PLC(CMPS)0200,000+200,00001,1060.09%+1,106
SAB Biotherapeutics Inc(SABS)11,420,00011,420,000042,71143,7393.64%+1,028
Tenax Therapeutics Inc(TENX)208,333208,33302,5403,3310.28%+792
Precision Biosciences Inc(DTIL)4,6754,675019260.00%+6
Sinovac Biotech Ltd.(SVA)5,903,0005,903,000038,19238,1923.17%0
Bolt Therapeutics Inc72,41472,41403962930.02%-103
Eupraxia Pharmaceuticals Inc(EPRX)1,350,0001,350,000010,1939,7740.81%-418
Compass Therapeutics Inc(CMPX)9,545,4669,545,466051,25950,4964.20%-764
Instil Bio Inc(TIL)292,743292,74303,2202,4120.20%-808
EnGene Holdings Inc
*W EXP 10/31/202
285,0460-285,0468440—-844
Monopar Therapeutics Inc(MNPR)90,50090,50005,9104,9580.41%-951
Pasithea Therapeutics Corp(KTTA)2,100,0002,100,00002,7091,5580.13%-1,151
Sera Prognostics Inc(SERA)1,650,4401,650,44004,8693,3500.28%-1,518
Aclaris Therapeutics, Inc.(ACRS)8,888,8886,666,666-2,222,22226,75625,0002.08%-1,756
Trevi Therapeutics Inc(TRVI)5,094,6685,094,668063,78560,7795.05%-3,006
Palisade Bio Inc(PALI)2,293,5780-2,293,5785,3900—-5,390
Silence Therapeutics PLC(SLN)1,105,4540-1,105,4546,7210—-6,721
Olema Pharmaceuticals Inc(OLMA)671,843671,843016,79610,0170.83%-6,779
CAMP4 Therapeutics Inc(CAMP)4,246,5684,246,568026,03118,7271.56%-7,304
Verastem Inc(VSTM)1,106,5240-1,106,5248,5420—-8,542
Abeona Therapeutics, Inc.(ABEO)1,842,7510-1,842,7519,7110—-9,711
Pepgen Inc(PEPG)2,325,0002,325,000015,1364,1150.34%-11,020
Cytomx Therapeutics Inc(CTMX)2,884,6150-2,884,61512,2880—-12,288
Abivax SA - ADR(ABVX)359,305239,539-119,76648,45426,6732.22%-21,781
Dyne Therapeutics Inc(DYN)2,614,9601,557,466-1,057,49451,14928,2372.35%-22,912
Geron Corp(GERN)27,225,2928,671,797-18,553,49535,93712,9211.07%-23,016
Viridian Therapeutics Inc(VRDN)982,576166,288-816,28830,5783,2530.27%-27,325
Zenas Biopharma Inc(ZBIO)853,4950-853,49530,9900—-30,990
Soleno Therapeutics Inc894,909294,909-600,00041,4349,8740.82%-31,561
Avadel Pharmaceuticals PLC2,684,1090-2,684,10957,8430—-57,843
Cogent Biosciences Inc(COGT)2,398,993422,300-1,976,69385,21216,2541.35%-68,958
Terns Pharmaceuticals Inc5,346,9281,334,418-4,012,510216,01670,3515.85%-145,665
Cidara Therapeutics, Inc.956,6700-956,670211,3190—-211,319
Page 1 of 1
Vivo Capital, LLC — 13F Holdings — Q1 2026 | TickerTrail